News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
305 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (3339)
February (3294)
March (4068)
April (3458)
May (4782)
June (3455)
July (2690)
August (3589)
September (3334)
October (3977)
November (4082)
December (2500)
Day
1 (201)
2 (268)
3 (272)
4 (305)
5 (108)
6 (6)
7 (10)
8 (235)
9 (334)
10 (239)
11 (333)
12 (116)
13 (2)
14 (3)
15 (255)
16 (204)
17 (173)
18 (167)
19 (88)
20 (9)
21 (8)
22 (183)
23 (215)
24 (191)
25 (218)
26 (104)
28 (2)
29 (12)
30 (225)
31 (296)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
28
29
30
31
Biotech Bay
BioMarin to Participate in Bank of America 2023 Health Care Conference
BioMarin Pharmaceutical Inc. announced that Brian Mueller, Executive Vice President, Chief Financial Officer of BioMarin will present at the Bank of America 2023 Health Care Conference on Wednesday, May 10, 2023 at 3:40pm PT, in Las Vegas, NV.
May 4, 2023
·
1 min read
BioCapital
Novavax to Participate in the BofA Securities 2023 Health Care Conference
Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, announced that it will participate in the BofA Securities 2023 Health Care Conference.
May 4, 2023
·
1 min read
Business
Heron Therapeutics to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
Heron Therapeutics, Inc. announced that the company will host a conference call and live webcast on Thursday, May 11, 2023 at 4:30 p.m. ET to report first quarter 2023 financial results and discuss recent business highlights.
May 4, 2023
·
2 min read
Bio NC
Congruence Therapeutics to Present at Multiple Investor Conferences in May 2023
Congruence Therapeutics, a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding, announced that management will participate in the following investor conferences.
May 4, 2023
·
1 min read
Business
Biolase to Report First Quarter 2023 Results on May 11, 2023
BIOLASE, Inc. announced that it will release first quarter 2023 financial and operating results on Thursday, May 11, 2023, after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results and corporate developments.
May 4, 2023
·
2 min read
Business
Cryoport Reports First Quarter 2023 Results
Cryoport, Inc., a leading global provider of innovative temperature-controlled supply chain solutions for the life sciences, announced financial results for the three months ended March 31, 2023.
May 4, 2023
·
26 min read
Business
Protagonist Reports First Quarter 2023 Financial Results and Provides Corporate Update
Protagonist Therapeutics reported financial results for the first quarter ended March 31, 2023, and provided a corporate update.
May 4, 2023
·
10 min read
Business
Cerus Corporation Announces First Quarter 2023 Financial Results
Cerus Corporation announced financial results for the first quarter ended March 31, 2023.
May 4, 2023
·
17 min read
Policy
Nucleix’s Bladder EpiCheck® Receives FDA 510(k) Clearance for Monitoring of Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence
Nucleix has received 510 clearance from the U.S. Food and Drug Administration to market Bladder EpiCheck® for use as a non-invasive method for surveillance of tumor recurrence in patients previously diagnosed with non-muscle invasive bladder cancer, in conjunction with cystoscopy.
May 4, 2023
·
4 min read
Business
Inogen Announces First Quarter 2023 Financial Results
Inogen, Inc., a medical technology company offering innovative respiratory products for use in the homecare setting, announced financial results for the quarter ended March 31, 2023.
May 4, 2023
·
13 min read
Previous
16 of 31
Next